[go: up one dir, main page]

WO1997040151A3 - Proteines secretees et polynucleotides les codant - Google Patents

Proteines secretees et polynucleotides les codant Download PDF

Info

Publication number
WO1997040151A3
WO1997040151A3 PCT/US1997/006125 US9706125W WO9740151A3 WO 1997040151 A3 WO1997040151 A3 WO 1997040151A3 US 9706125 W US9706125 W US 9706125W WO 9740151 A3 WO9740151 A3 WO 9740151A3
Authority
WO
WIPO (PCT)
Prior art keywords
secreted proteins
polynucleotides encoding
cdna library
clones
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1997/006125
Other languages
English (en)
Other versions
WO1997040151A2 (fr
Inventor
Kenneth Jacobs
John M Mccoy
Lisa A Racie
Edward R Lavallie
David Merberg
Vikki Spaulding
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genetics Institute LLC
Original Assignee
Genetics Institute LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Institute LLC filed Critical Genetics Institute LLC
Priority to AU27286/97A priority Critical patent/AU2728697A/en
Priority to JP9538135A priority patent/JP2000508908A/ja
Priority to EP97921171A priority patent/EP0954577A2/fr
Publication of WO1997040151A2 publication Critical patent/WO1997040151A2/fr
Publication of WO1997040151A3 publication Critical patent/WO1997040151A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention a trait à cinq clones G52-24, H1075-1, J59-41, H83-22 et J143-1, provenant d'une banque d'ADNc d'hématocrites mononucléaires humains périphériques (PBMC), ainsi qu'à un clone M97-2 provenant d'une banque d'ADNc T98G (lignée cellulaire d'un glioblastome humain). Ces clones ont été isolés par criblage d'ADNc codant des protéines sécrétées. L'invention a également trait à une détermination de séquences nucléotidiques ainsi qu'à des séquences d'acides aminés déduites.
PCT/US1997/006125 1996-04-19 1997-04-14 Proteines secretees et polynucleotides les codant Ceased WO1997040151A2 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU27286/97A AU2728697A (en) 1996-04-19 1997-04-14 Secreted proteins and polynucleotides encoding them
JP9538135A JP2000508908A (ja) 1996-04-19 1997-04-14 分泌蛋白およびそれらをコードしているポリヌクレオチド
EP97921171A EP0954577A2 (fr) 1996-04-19 1997-04-14 Proteines secretees et polynucleotides les codant

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US63531196A 1996-04-19 1996-04-19
US08/635,311 1996-04-19
US78122697A 1997-01-10 1997-01-10
US08/781,226 1997-01-10

Publications (2)

Publication Number Publication Date
WO1997040151A2 WO1997040151A2 (fr) 1997-10-30
WO1997040151A3 true WO1997040151A3 (fr) 1998-02-05

Family

ID=27092348

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/006125 Ceased WO1997040151A2 (fr) 1996-04-19 1997-04-14 Proteines secretees et polynucleotides les codant

Country Status (5)

Country Link
EP (1) EP0954577A2 (fr)
JP (1) JP2000508908A (fr)
AU (1) AU2728697A (fr)
CA (1) CA2251934A1 (fr)
WO (1) WO1997040151A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8101349B2 (en) 1997-12-23 2012-01-24 Novartis Vaccines And Diagnostics, Inc. Gene products differentially expressed in cancerous cells and their methods of use II
EP1179015A1 (fr) 1999-03-25 2002-02-13 Bristol-Myers Squibb Company Molecules d'adn codant pour des proteines clax humaines et leurs proteines de fusion solubles
JP2003518920A (ja) * 1999-07-02 2003-06-17 カイロン コーポレイション 新規なヒト遺伝子および遺伝子発現産物
US7939282B2 (en) * 2004-10-21 2011-05-10 Rhode Island Hospital Methods for detecting sepsis
US7842467B1 (en) 2005-05-12 2010-11-30 Celera Corporation Breast disease targets and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536637A (en) * 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536637A (en) * 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
ENG MONG LIM ET AL: "IDENTIFICATION OF MYCOBACTERIUM TUBERCULOSIS DNA SEQUENCES ENCODING EXPORTED PROTEINS BY USING PHOA GENE FUSIONS", JOURNAL OF BACTERIOLOGY, vol. 177, no. 1, 1 January 1995 (1995-01-01), pages 59 - 65, XP000560419 *
HILLIER H . EET AL: "The WashU-Merck EST project : za49a11.s1 homo sapiens cDNA clone 295868 .", EMBL DATABASE ENTRY HS 007301 .ACCESSION NUMBER N67007( VERSION 2), 9 April 1996 (1996-04-09), XP002039159 *
K. JACOBS ET AL: "A novel method for isolating eukaryotic cDNA clones encoding secreted proteins", JOURNAL OF CELLULAR BIOCHEMISTRY, vol. 21A, no. suppl0, 10 March 1995 (1995-03-10) - 4 April 1995 (1995-04-04), pages 19, XP002027246 *
L. HILLIER ET AL: "The WashU-Merck EST project", EMBL DATABASE ENTRY . HSA29932 . ACESSION NUMBER : AA029932, 20 August 1996 (1996-08-20), XP002039170 *
L. HILLIER ET AL: "The WashU-Merck EST project", EMBL DATABASE ENTRY HSA28937 . ACCESSION NUMBER : AA028937, 20 August 1996 (1996-08-20), XP002039158 *
L.HILLIER ET AL: "The WashU-Merck EST project .", EMBL DATABASE ENTRY HS 30080, ACCESSION NUMBER R12300(VERSION 1), 21 April 1995 (1995-04-21), XP002039157 *
R.E. CALLARD , A. J.H. GEARING: "the cytokine factsbook", 1994, ACADEMIC PRESS HARCOURT BRACE & COMPANY, PUBLISHERS, LONDON, XP002039160, 209420 *

Also Published As

Publication number Publication date
WO1997040151A2 (fr) 1997-10-30
JP2000508908A (ja) 2000-07-18
EP0954577A2 (fr) 1999-11-10
CA2251934A1 (fr) 1997-10-30
AU2728697A (en) 1997-11-12

Similar Documents

Publication Publication Date Title
WO2001088092A3 (fr) Procedes et materiaux relatifs aux polypeptides et polynucleotides du type facteur des cellules souches (du type fcs)
EP1308459A3 (fr) Séquences d'ADN complementaires pleine longueur
IL205233A0 (en) A polypeptide comprising the amino acid sequence of osteoprotegerin from residues 22 to 401 inclusive, or a fragment or trunaction thereof
WO2000005366A3 (fr) Sequence ires du gene xiap et ses utilisations
HU9601448D0 (en) Novel apoptosis-modulating proteins, dna encoding the proteins and methods of use thereof
WO2001055336A3 (fr) Procedes et substances relatifs a des polypeptides de type cd84 et a des polynucleotides
WO2001077169A3 (fr) Methodes et materiaux relatifs a de nouveaux polypeptides et polynucleotides du type facteur de croissance des cellules-souches
WO2001053454A3 (fr) Procedes et elements ayant trait a des polypeptides et des polynucleotides de type recepteurs couples a une proteine g
DK0994115T3 (da) Fremgangsmåde til fremstilling af pyrazolo-(4,3-d)pyrimidin-7-oner og mellemprodukter deraf
WO2004031362A3 (fr) Ingenierie des proteines multimeriques
WO1997040151A3 (fr) Proteines secretees et polynucleotides les codant
WO1997040069A3 (fr) Proteines secretees et polynucleotides les codant
WO2003070751A3 (fr) Mimetiques peptidiques partiels et procedes associes
WO1997046682A3 (fr) Polynucleotides issus des proteines secretees par l'adultes humains et codant pour les pbmc
WO2001055335A3 (fr) Procedes et materiaux se rapportant a des polypeptides et polynucleotides semblables a des recepteurs de leucocytes de type immunoglobuline (lir)
EP1574520A3 (fr) Polypeptides et polynucléotides ressemblant à la molécule de guidage neuronale ainsi que méthodes et matériaux dérivés
WO1997038084A3 (fr) Polynucleotides codant des proteines secretees
WO2001053500A8 (fr) Procedes et substances relatifs a des polypeptides de type facteur de croissance de cellules souches et a des polynucleotides
WO1997048801A3 (fr) Polynucleotides codant des proteines secretees
WO2001075064A3 (fr) Methode et materiels relatifs a des polypeptides et a des polynucleotides semblables a la proteine de liaison au facteur de croissance semblable a l'insuline
EP0797588A4 (fr) POLYPEPTIDES SPECIFIQUES DE LA SOUS-UNITE BETA 3? DE L'INTEGRINE, ADNc CODANT CES POLYPEPTIDES ET PROCEDES DE PRODUCTION DE CES POLYPEPTIDES
WO2001053456A8 (fr) Procedes et substances relatifs a des polypeptides de type prothrombinase et a des polynucleotides
WO1996005300A3 (fr) Or-1 sur recepteur orphelin appartenant a la famille des recepteurs nucleaires
WO2001055337A3 (fr) Procedes et substances relatifs a des polypeptides de type antigene carcino-embryonnaire (cea) et a des polynucleotides
WO1998024896A3 (fr) Muteines de la proteine de l'obesite

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP MX

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2251934

Country of ref document: CA

Ref country code: CA

Ref document number: 2251934

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1997921171

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1997921171

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1997921171

Country of ref document: EP